Table 2.
Cytogenetic profile of CML-AP patients.
| Sl. No | Recurrent karyotype | No. of cases |
|---|---|---|
| 1 | 46,XY,t(9;22)(q34;q11)[20] | 14 |
| 2 | 46,XX,t(9;22)(q34;q11)[20] | 5 |
| 3 | 47,XX,t(9;22)(q34;q11),+der(22)t(9;22)[20] | 2 |
| 4 | 47,XY,t(9;22)(q34;q11),+der(22)t(9;22)[20] | 1 |
| 5 | 46,XY,t(9;22)(q34;q11)[15]/47,XY,t(9;22)(q34;q11),+der(22)t(9;22)[5] | 1 |
| 6 | 46,XY,t(9;22)(q34;q11)[17]/47,XY,+8,t(9;22)(q34;q11)[3] | 1 |
| 7 | 46,XX,t(9;22)(q34;q11),dup(17)(q24)[20] | 1 |
| 8 | 46,XX,t(9;22)(q34;q11)[12]/49,XX,+9,t(9;22)(q34;q11),+21,+22[8] | 1 |
| 9 | 46,XX,t(9;22)(q34;q11),dup(16)(q24)[20] | 1 |
| 10 | 47,XX,t(9;22)(q34;q11),+13[13]/46,XX,t(9;22)(q34;q11)[7] | 1 |
| 11 | Moderate hyperdiploidy, 2n = 47–50[20] | 1 |
| 12 | 46,XY,t(9;22)(q34;q11)[14]/92 <4n>,XXYY[6] | 1 |
| 13 | Karyotype failure | 6 |
| NOVEL KARYOTYPE | ||
| 14 | 46,XX,t(9;22)(q34;q11),r(10)(p15q26)[20] | 1 |
| 15 | 46,XY,t(9;22)(q34;q11),ins(11;18)(p15;q21q23)[20] | 1 |